Ben Davies,
Group Leader,
University of Oxford
Dr. Ben Davies received his PhD in molecular biology from the University of Edinburgh where he first encountered gene targeting techniques at the Centre for Genome Research. After a postdoc at the Charite Hospital Berlin, he moved into commercial biotech working as scientific director for a start-up transgenic service company based at the University Hospital Hamburg-Eppendorf which was then merged with the French Biotech company, Genoway. After 4 years in this role, he moved to Oxford where he runs the transgenic core research group at the Wellcome Trust Centre for Human Genetics at the University of Oxford, a position he has held for the last 8 years.
|
|
|
Add to Calendar ▼2015-10-07 15:30:002015-10-07 16:30:00Europe/LondonEfficient CRISPR/Cas9 Genome Engineering using Zygotes and Embryos Derived from Cas9 Overexpressing Transgenic MiceGenome Engineering in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.com
